Preferred Label : Carnitine deficiency, systemic primary;
Symbol : CDSP;
CISMeF acronym : CDSP; CUD; SCD;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Carnitine deficiency, systemic, due to defect in renal reabsorption of carnitine; Carnitine deficiency, primary; CUD; SCD; Carnitine uptake defect; Carnitine transporter, plasma-membrane, deficiency of; Systemic carnitine deficiency;
Description : Primary systemic carnitine deficiency is due to a defect in the high-affinity carnitine
transporter expressed in muscle, heart, kidney, lymphoblasts, and fibroblasts. This
results in impaired fatty acid oxidation in skeletal and heart muscle. In addition,
renal wasting of carnitine results in low serum levels and diminished hepatic uptake
of carnitine by passive diffusion, which impairs ketogenesis (Lamhonwah et al., 2002).
See also myopathic carnitine deficiency (212160), which is restricted to skeletal
muscle.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the solute carrier family 22 (organic cation transporter), member
5 gene (SLC22A5, 603377.0001).;
Laboratory abnormalities : Abnormal liver enzymes; Increased urinary carnitine; Decreased carnitine in serum, muscle, heart, and liver; Impaired carnitine uptake in muscle, heart, kidney, fibroblasts, and lymphocytes; Hyperammonemia; No dicarboxylic aciduria; No ketosis;
Prefixed ID : #212140;
Origin ID : 212140;
UMLS CUI : C0342788;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
Not associated HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)